Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. (Q53253372)
Jump to navigation
Jump to search
scientific article published on 21 June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. |
scientific article published on 21 June 2006 |
Statements
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. (English)
1 reference
1 reference
Witold Ruzyllo
1 reference
W Douglas Weaver
1 reference
Michael P Hudson
1 reference
Jose Brum
1 reference
Lisa Cusmano
1 reference
Piotr Krzeski
1 reference
Robert Lyon
1 reference
Miguel Quinones
1 reference
Pierre Theroux
1 reference
Diana Sydlowski
1 reference
Henry E Kim
1 reference
Mario J Garcia
1 reference
Wael A Jaber
1 reference
21 June 2006
1 reference
48
1 reference
15-20
1 reference
1
1 reference
Identifiers
1 reference